Alliance Pharma has reported a 10 % increase in pre - tax profit of £ 28.4 m ( $ 40 m ) for the year ending December 2017 , while revenue rose 6 % to £ 24 m . The company also said underlying pre - tax profit increased 8 % to £ 24 ##m , and despite spending spending £ ##3 m on acquisitions , net profit was reduced to £ 72.3 m from the 2016 figure of £ 76.1 ##m .
Alliance Pharma has reported a 28% increase in pre-tax profit of £28.4m ($40m) for the year ending December 2017, while revenue rose 6% to £103.3m. The company also said underlying pre-tax profit rose 8% to £24m, and despite spending spending £16m on acquisitions, net debt was reduced to £72.3m from the 2016 figure of £76.1m.